Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro

Frontiers Endocytosis and Transcytosis of SARS-CoV-2 Across the

Frontiers Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface

Frontiers Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19

Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies - Troyer - 2021 - Journal of Extracellular Vesicles - Wiley Online Library

Spike, S1, RBD, SARS-CoV-2 plasmids

Frontiers Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design

Spike expressing HEK293 cells, COVID-19 studies

Frontiers Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants

Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine

Frontiers Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits

Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants

Frontiers Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2